| Product Code: ETC7372928 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of intravenous antibodies to Grenada in 2024 showed a diversification of sources, with top exporting countries including Saint Lucia, Barbados, Ireland, USA, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) indicated a shift from high to moderate concentration from 2023 to 2024, reflecting a more balanced market landscape. Despite a negative Compound Annual Growth Rate (CAGR) of -3.58% from 2020 to 2024, there was a positive growth rate of 3.24% from 2023 to 2024, suggesting potential opportunities for market expansion and development in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Intravenous Antibodies Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Intravenous Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Intravenous Antibodies Market - Industry Life Cycle |
3.4 Grenada Intravenous Antibodies Market - Porter's Five Forces |
3.5 Grenada Intravenous Antibodies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Intravenous Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Grenada Intravenous Antibodies Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Intravenous Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Intravenous Antibodies Market Trends |
6 Grenada Intravenous Antibodies Market, By Types |
6.1 Grenada Intravenous Antibodies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Intravenous Antibodies Market Revenues & Volume, By IgG, 2021- 2031F |
6.1.4 Grenada Intravenous Antibodies Market Revenues & Volume, By IgA, 2021- 2031F |
6.1.5 Grenada Intravenous Antibodies Market Revenues & Volume, By IgM, 2021- 2031F |
6.1.6 Grenada Intravenous Antibodies Market Revenues & Volume, By IgE, 2021- 2031F |
6.1.7 Grenada Intravenous Antibodies Market Revenues & Volume, By IgD, 2021- 2031F |
6.2 Grenada Intravenous Antibodies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Grenada Intravenous Antibodies Market Revenues & Volume, By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), 2021- 2031F |
6.2.4 Grenada Intravenous Antibodies Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura, 2021- 2031F |
6.2.5 Grenada Intravenous Antibodies Market Revenues & Volume, By Hypogammaglobulinemia, 2021- 2031F |
6.2.6 Grenada Intravenous Antibodies Market Revenues & Volume, By Myasthenia Gravis, 2021- 2031F |
6.2.7 Grenada Intravenous Antibodies Market Revenues & Volume, By Multifocal Motor Neuropathy, 2021- 2031F |
6.2.8 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Intravenous Antibodies Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Grenada Intravenous Antibodies Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Intravenous Antibodies Market Import-Export Trade Statistics |
7.1 Grenada Intravenous Antibodies Market Export to Major Countries |
7.2 Grenada Intravenous Antibodies Market Imports from Major Countries |
8 Grenada Intravenous Antibodies Market Key Performance Indicators |
9 Grenada Intravenous Antibodies Market - Opportunity Assessment |
9.1 Grenada Intravenous Antibodies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Intravenous Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Grenada Intravenous Antibodies Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Intravenous Antibodies Market - Competitive Landscape |
10.1 Grenada Intravenous Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Grenada Intravenous Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here